The emergence of antibiotic resistance by mutation
Open accessAbstract
The emergence of mutations in nucleic acids is one of the major factors underlying evolution, providing the working material for natural selection. Most bacteria are haploid for the vast majority of their genes and, coupled with typically short generation times, this allows mutations to emerge and accumulate rapidly, and to effect significant phenotypic changes in what is perceived to be real-time. Not least among these phenotypic changes are those associated with antibiotic resistance. Mechanisms of horizontal gene spread among bacterial strains or species are often considered to be the main mediators of antibiotic resistance. However, mutational resistance has been invaluable in studies of bacterial genetics, and also has primary clinical importance in certain bacterial species, such as Mycobacterium tuberculosis and Helicobacter pylori, or when considering resistance to particular antibiotics, especially to synthetic agents such as fluoroquinolones and oxazolidinones. In addition, mutation is essential for the continued evolution of acquired resistance genes and has, e.g., given rise to over 100 variants of the TEM family of beta-lactamases. Hypermutator strains of bacteria, which have mutations in genes affecting DNA repair and replication fidelity, have elevated mutation rates. Mutational resistance emerges de novo more readily in these hypermutable strains, and they also provide a suitable host background for the evolution of acquired resistance genes in vitro. In the clinical setting, hypermutator strains of Pseudomonas aeruginosa have been isolated from the lungs of cystic fibrosis patients, but a more general role for hypermutators in the emergence of clinically relevant antibiotic resistance in a wider variety of bacterial pathogens has not yet been proven.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Hypermutator phenotypes resulting from mutations in DNA repair genes have been proposed to precede the appearance of resistance in bacteria.
“Furthermore, the appearance of ‘hypermutator phenotypes’ resulting from mutations in DNA repair genes has been proposed to precede the appearance of resistance in bacteria [133].”
From Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens (2018) · cites this paper as [133]
Cites
On the Origin of Species by Means of Natural Selection
Livezey, R. L., & Darwin, C. R. (1953) · The American Midland Naturalist · doi:10.2307/2485224 · Cited by 5,430 · see citing works
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,646 · see citing works
Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG
Shibutani, S., Takeshita, M., & Grollman, A. P. (1991) · Nature · doi:10.1038/349431a0 · Cited by 2,224 · see citing works
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,731 · see citing works
MISMATCH REPAIR IN REPLICATION FIDELITY, GENETIC RECOMBINATION, AND CANCER BIOLOGY
Modrich, P. L., & Lahue, R. S. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.000533 · Cited by 1,510 · see citing works
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494 · see citing works
THE ORIGIN OF SPECIES BY MEANS OF NATURAL SELECTION
Gray, A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511693281.002 · Cited by 1,487 · see citing works
Multiple Mechanisms of Antimicrobial Resistance in Pseudomonas aeruginosa: Our Worst Nightmare?
Livermore, D. M. (2002) · Clinical Infectious Diseases · doi:10.1086/338782 · Cited by 1,470 · see citing works
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,466 · see citing works
A constant rate of spontaneous mutation in DNA-based microbes.
Drake, J. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7160 · Cited by 1,199 · see citing works
Antibiotics in laboratory medicine
(1997) · doi:10.1016/s0732-8893(97)00063-1 · Cited by 1,036 · see citing works
Linezolid resistance in a clinical isolate of Staphylococcus aureus
Tsiodras, S., Gold, H. S., Sakoulas, G., Eliopoulos, G. M., Wennersten, C. B., Venkataraman, L., Moellering, R. C., & Ferraro, M. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05410-1 · Cited by 1,034 · see citing works
Recombinational Repair of DNA Damage in Escherichia coli and Bacteriophage λ
Kuzminov, A. (1999) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.63.4.751-813.1999 · Cited by 897 · see citing works
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 887 · see citing works
Evolution of high mutation rates in experimental populations of E. coli
Sniegowski, P. D., Gerrish, P. J., & Lenski, R. E. (1997) · Nature · doi:10.1038/42701 · Cited by 879 · see citing works
The importance of efflux pumps in bacterial antibiotic resistance
Webber, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg050 · Cited by 856 · see citing works
High Mutation Frequencies Among Escherichia coli and Salmonella Pathogens
LeClerc, J. E., Li, B., Payne, W. L., & Cebula, T. A. (1996) · Science · doi:10.1126/science.274.5290.1208 · Cited by 818 · see citing works
Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance
Hiramatsu, K. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00091-3 · Cited by 761 · see citing works
Ruiz, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg222 · Cited by 726 · see citing works
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 686 · see citing works
Role of mutator alleles in adaptive evolution
Taddéi, F., Radman, M., Smith, J. M., Toupance, B., Gouyon, P. H., & Godelle, B. (1997) · Nature · doi:10.1038/42696 · Cited by 678 · see citing works
The fluoroquinolone antibacterials: past, present and future perspectives
Appelbaum, P. C., & Hunter, P. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(00)00192-8 · Cited by 631 · see citing works
DNA MISMATCH REPAIR AND GENETIC INSTABILITY
Harfe, B. D., & Jinks-Robertson, S. (2000) · Annual Review of Genetics · doi:10.1146/annurev.genet.34.1.359 · Cited by 605 · see citing works
Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
Gonzales, R. D., Schreckenberger, P. C., Graham, M. B., Kelkar, S., DenBesten, K., & Quinn, J. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04376-2 · Cited by 542 · see citing works
Walther‐Rasmussen, J., & Høiby, N. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki482 · Cited by 497 · see citing works
Cell Wall Thickening Is a Common Feature of Vancomycin Resistance in Staphylococcus aureus
Cui, L., Ma, X., Sato, K., Okuma, K., Tenover, F. C., Mamizuka, E. M., Gemmell, C. G., Kim, M., Ploy, M.-C., Solh, N. E., et al. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.1.5-14.2003 · Cited by 495 · see citing works
Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms.
Poole, K. (2001) · PubMed · Cited by 450 · see citing works
Effects of Environment on Compensatory Mutations to Ameliorate Costs of Antibiotic Resistance
Björkman, J., Нагаев, И. Ю., Berg, O. G., Hughes, D., & Andersson, D. I. (2000) · Science · doi:10.1126/science.287.5457.1479 · Cited by 449 · see citing works
Evolution and spread of antibiotic resistance
Normark, B. H., & Normark, S. J. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01026.x · Cited by 441 · see citing works
Evolution of Drug Resistance in Mycobacterium tuberculosis : Clinical and Molecular Perspective
Gillespie, S. H. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.267-274.2002 · Cited by 420 · see citing works
Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori
Björkholm, B., Sjölund, M., Falk, P. G., Berg, O. G., Engstrand, L. G., & Andersson, D. I. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241517298 · Cited by 404 · see citing works
Adaptation to the fitness costs of antibiotic resistance inEscherichia coli
Schrag, S. J., Perrot, V., & Levin, B. R. (1997) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1997.0178 · Cited by 401 · see citing works
The mar regulon: multiple resistance to antibiotics and other toxic chemicals
Alekshun, M. N., & Levy, S. B. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01589-9 · Cited by 399 · see citing works
Ferrero, L., Cameron, B., Manse, B., Lagneaux, D., Crouzet, J., Famechon, A., & Blanche, F. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb00458.x · Cited by 378 · see citing works
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1020-1027.1998 · Cited by 377 · see citing works
Barbosa, T. M., & Levy, S. B. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.12.3467-3474.2000 · Cited by 373 · see citing works
Highly Variable Mutation Rates in Commensal and Pathogenic Escherichia coli
Matić, I., Radman, M., Taddéi, F., Picard, B., Doit, C., Bingen, É., Denamur, É., & Élion, J. (1997) · Science · doi:10.1126/science.277.5333.1833 · Cited by 368 · see citing works
Hanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 367 · see citing works
Everett, M. J., Jin, Y., Ricci, V., & Piddock, L. J. V. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365 · see citing works
Sakoulas, G., Eliopoulos, G. M., Moellering, R. C., Wennersten, C. B., Venkataraman, L., Novick, R. P., & Gold, H. S. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1492-1502.2002 · Cited by 364 · see citing works
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O'Hara, C. M., McAllister, S. K., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.2167-2167.1998 · Cited by 362 · see citing works
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 361 · see citing works
Arthur, M., Molinas, C., & Courvalin, P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.8.2582-2591.1992 · Cited by 338 · see citing works
β-Lactamases of <i>Kluyvera ascorbata</i> , Probable Progenitors of Some Plasmid-Encoded CTX-M Types
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R., & Philippon, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3045-3049.2002 · Cited by 338 · see citing works
Lee, K., Yum, J. H., Yong, D., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333 · see citing works
Moise-Broder, P. A., Sakoulas, G., Eliopoulos, G. M., Schentag, J. J., Forrest, A., & Moellering, R. C. (2004) · Clinical Infectious Diseases · doi:10.1086/421092 · Cited by 332 · see citing works
Toleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 329 · see citing works
Carbapenemases: a problem in waiting?
Livermore, D. M., & Woodford, N. (2000) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(00)00128-4 · Cited by 324 · see citing works
Self-citationCui, L., Murakami, H., Kuwahara‐Arai, K., Hanaki, H., & Hiramatsu, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2276-2285.2000 · Cited by 320 · see citing works
Detection of β-lactamase-mediated resistance
Livermore, D. M., & Brown, D. F. J. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.suppl_1.59 · Cited by 307 · see citing works
Base selection, proofreading, and mismatch repair during DNA replication in Escherichia coli.
Schaaper, R. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80446-3 · Cited by 305 · see citing works
Current perspectives on glycopeptide resistance
Woodford, N., Johnson, A. P., Morrison, D., & Speller, D. C. E. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.585 · Cited by 298 · see citing works
Self-citationMethyl-directed DNA Mismatch Correction
Modrich, P. L. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83467-6 · Cited by 291 · see citing works
Linezolid resistance in clinical isolates of Staphylococcus aureus
Wilson, P. R. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg104 · Cited by 291 · see citing works
Mechanisms of quinolone action and microbial response
Hawkey, P. M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg207 · Cited by 290 · see citing works
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284 · see citing works
Wang, H., Dzink-Fox, J., Chen, M., & Levy, S. B. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1515-1521.2001 · Cited by 284 · see citing works
Sieradzki, K., & Tomasz, A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.8.2557-2566.1997 · Cited by 276 · see citing works
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 268 · see citing works
Oliver, A., Baquero, F., & Blázquez, J. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02855.x · Cited by 267 · see citing works
Singh, K. V., Weinstock, G. M., & Murray, B. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1845-1850.2002 · Cited by 263 · see citing works
Gene Dosage and Linezolid Resistance in <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>
Marshall, S. H., Donskey, C. J., Hutton-Thomas, R., Salata, R. A., & Rice, L. B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3334-3336.2002 · Cited by 263 · see citing works
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
Нагаев, И. Ю., Björkman, J., Andersson, D. I., et al. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02389.x · Cited by 257 · see citing works
SPONTANEOUS MUTATORS IN BACTERIA: Insights into Pathways of Mutagenesis and Repair
Miller, J. H. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.micro.50.1.625 · Cited by 255 · see citing works
COMPETITION BETWEEN HIGH AND LOW MUTATING STRAINS OF<i>ESCHERICHIA COLI</i>
Chao, L., & Cox, E. C. (1983) · Evolution · doi:10.1111/j.1558-5646.1983.tb05521.x · Cited by 255 · see citing works
Meka, V. G., Pillai, S. K., Sakoulas, G., Wennersten, C. B., Venkataraman, L., DeGirolami, P. C., Eliopoulos, G. M., Moellering, R. C., & Gold, H. S. (2004) · The Journal of Infectious Diseases · doi:10.1086/421471 · Cited by 246 · see citing works
The role of mutators in the emergence of antibiotic-resistant bacteria
Chopra, I., O’Neill, A. J., & Miller, K. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00041-4 · Cited by 245 · see citing works
Gales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 243 · see citing works
Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
Orencia, M. C., Yoon, J. S., Ness, J. E., Stemmer, W. P. C., & Stevens, R. C. (2001) · Nature Structural Biology · doi:10.1038/84981 · Cited by 239 · see citing works
Jalal, S., Ciofu, O., Høiby, N., Gotoh, N., & Wretlind, B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.710-712.2000 · Cited by 236 · see citing works
Evers, S., & Courvalin, P. M. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1302-1309.1996 · Cited by 229 · see citing works
Múñoz, R., & de la Campa, A. G. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2252 · Cited by 226 · see citing works
Reduced susceptibility of Staphylococcus aureus to vancomycin—Japan, 1996
(1997) · American Journal of Infection Control · doi:10.1016/s0196-6553(97)90087-0 · Cited by 224 · see citing works
Oethinger, M. D., Kern, W. V., Jellen-Ritter, A., McMurry, L. M., & Levy, S. B. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.10-13.2000 · Cited by 213 · see citing works
Mechanism of action of the oxazolidinone antibacterial agents
Shinabarger, D. L. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.8.1195 · Cited by 213 · see citing works
Hypermutation as a Factor Contributing to the Acquisition of Antimicrobial Resistance
Eliopoulos, G. M., & Blázquez, J. (2003) · Clinical Infectious Diseases · doi:10.1086/378810 · Cited by 206 · see citing works
Jacobs, C., Joris, B., Jamin, M., et al. (1995) · Molecular Microbiology · doi:10.1111/j.1365-2958.1995.tb02268.x · Cited by 204 · see citing works
Prunier, A., Malbruny, B., Laurans, M., Brouard, J., Duhamel, J.-F., & Leclercq, R. (2003) · The Journal of Infectious Diseases · doi:10.1086/374937 · Cited by 198 · see citing works
OXA β-lactamases in Acinetobacter: the story so far
Brown, S., & Amyes, S. G. B. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki425 · Cited by 190 · see citing works
Microbiology of lung infection in cystic fibrosis
Govan, J. R. W., & Nelson, J. W. (1992) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072585 · Cited by 189 · see citing works
Escherichia coli mutator genes
Horst, J. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01424-3 · Cited by 181 · see citing works
Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp
Kaye, K. S., Cosgrove, S. E., Harris, A. D., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2628-2630.2001 · Cited by 181 · see citing works
High Frequency of Mutator Strains among Human Uropathogenic Escherichia coli Isolates
Denamur, É., Bonacorsi, S., Giraud, A., Duriez, P., Hilali, F., Amorin, C., Bingen, É., Andremont, A., Picard, B., Taddéi, F., et al. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.2.605-609.2002 · Cited by 177 · see citing works
Tankovic, J., Périchon, B., Duval, J., et al. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2505 · Cited by 175 · see citing works
Schneiders, T., Amyes, S. G. B., & Levy, S. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2831-2837.2003 · Cited by 169 · see citing works
Virulence gene regulation by peptides in staphylococci and other Gram-positive bacteria
Novick, R. P., & Muir, T. W. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)80007-1 · Cited by 164 · see citing works
Mutator clones of Neisseria meningitidis in epidemic serogroup A disease
Richardson, A. R., Yu, Z., Popović, T., & Stojiljković, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092568699 · Cited by 164 · see citing works
The Discovery of Linezolid, the First Oxazolidinone Antibacterial Agent
Ford, C., Zurenko, G. E., & Barbachyn, M. R. (2001) · Current Drug Targets - Infectious Disorders · doi:10.2174/1568005014606099 · Cited by 159 · see citing works
Hanaki, H., Labischinski, H., Inaba, Y., Kondo, N., Murakami, H., & Hiramatsu, K. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.3.315 · Cited by 155 · see citing works
The multiple antibiotic resistance (mar) locus and its significance
Randall, L. P., & Woodward, M. J. (2002) · Research in Veterinary Science · doi:10.1053/rvsc.2001.0537 · Cited by 154 · see citing works
Wolter, N., Smith, A. M., Farrell, D. J., Schaffner, W., Moore, M. R., Whitney, C. G., Jorgensen, J. H., & Klugman, K. P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3554-3557.2005 · Cited by 152 · see citing works
Effect of D240G substitution in a novel ESBL CTX-M-27
Bonnet, R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg256 · Cited by 152 · see citing works
Linezolid-resistant enterococci: report of the first isolates in the United Kingdom
Auckland, C. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf246 · Cited by 151 · see citing works
van Doorn, L., Glupczynski, Y., Kusters, J. G., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1500-1504.2001 · Cited by 149 · see citing works
Lindberg, F. P., Lindquist, S., & Normark, S. J. (1987) · Journal of Bacteriology · doi:10.1128/jb.169.5.1923-1928.1987 · Cited by 146 · see citing works
Predicting the evolution of antibiotic resistance genes
Hall, B. G. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro888 · Cited by 143 · see citing works
Mechanisms of Quinolone Resistance in Clinical Strains of Pseudomonas aeruginosa
Jalal, S., & Wretlind, B. (1998) · Microbial Drug Resistance · doi:10.1089/mdr.1998.4.257 · Cited by 140 · see citing works
Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci
Woodford, N. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01140.x · Cited by 138 · see citing works
Self-citationChisholm, S., Owen, R. J., Teare, E. L., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.4.1217-1220.2001 · Cited by 133 · see citing works
Decousser, J. ‐., Poirel, L., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3595-3598.2001 · Cited by 133 · see citing works
AmpC -lactamases: what do we need to know for the future?
Hanson, N. D. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg284 · Cited by 130 · see citing works
Arthur, M., Depardieu, F., Gerbaud, G., Galimand, M., Leclercq, R., & Courvalin, P. M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.1.97-106.1997 · Cited by 126 · see citing works
Ford, P. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh251 · Cited by 125 · see citing works
Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria
Heritage, J. C., M'Zali, F. H., Gascoyne‐Binzi, D., et al. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.3.309 · Cited by 123 · see citing works
TB drug discovery: addressing issues of persistence and resistance
Smith, C. V., Sharma, V., & Sacchettini, J. C. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.08.019 · Cited by 120 · see citing works
Competition Between High and Low Mutating Strains of Escherichia coli
Chao, L., & Cox, E. C. (1983) · Evolution · doi:10.2307/2408181 · Cited by 119 · see citing works
Johnson, A. P., Tysall, L., Stockdale, M., Woodford, N., Kaufmann, M. E., Warner, M., Livermore, D. M., Asboth, F., & Allerberger, F. J. (2002) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-002-0807-0 · Cited by 118 · see citing works
Self-citationPfeltz, R. F., Singh, V. K., Schmidt, J. L., Batten, M. A., Baranyk, C. S., Nadakavukaren, M. J., Jayaswal, R. K., & Wilkinson, B. J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.294-303.2000 · Cited by 118 · see citing works
Alovero, F. L., Pan, X.-S., Morris, J. E., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.320-325.2000 · Cited by 115 · see citing works
Sirot, D., Recule, C., Chaibi, E. B., Bret, L., Croizé, J., Chanal, C., Labia, R., & Sirot, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1322 · Cited by 110 · see citing works
tcaA Inactivation Increases Glycopeptide Resistance in Staphylococcus aureus
Maki, H., Holmes, N., Bischoff, M., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.1953-1959.2004 · Cited by 110 · see citing works
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases
Walther‐Rasmussen, J., & Høiby, N. (2004) · Canadian Journal of Microbiology · doi:10.1139/w03-111 · Cited by 108 · see citing works
Dailidiene, D., Bertoli, M. T., Miciuleviciene, J., Mukhopadhyay, A. K., Dailide, G., Pascasio, M. A., Kupcinskas, L., & Berg, D. E. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3940-3946.2002 · Cited by 101 · see citing works
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori
Okamoto, T. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf140 · Cited by 100 · see citing works
Mutator Bacteria as a Risk Factor in Treatment of Infectious Diseases
Giraud, A., Matić, I., Radman, M., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.863-865.2002 · Cited by 98 · see citing works
Molecular testing for antibiotic resistance in Helicobacter pylori
Owen, R. J. (2002) · Gut · doi:10.1136/gut.50.3.285 · Cited by 97 · see citing works
Sinclair, A., Arnold, C. E., & Woodford, N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3620-3622.2003 · Cited by 97 · see citing works
Self-citationBaquero, M.-R., Nilsson, A. I., Turrientes, M. D. C., Sandvang, D., Galán, J. C., Martínez, J. L., Frimodt‐Møller, N., Baquero, F., & Andersson, D. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.16.5538-5542.2004 · Cited by 92 · see citing works
β-Lactamases: protein evolution in real time
Petrosino, J. F., Cantu, C., & Palzkill, T. G. (1998) · Trends in Microbiology · doi:10.1016/s0966-842x(98)01317-1 · Cited by 92 · see citing works
The threat from the pink corner
Livermore, D. M. (2003) · Annals of Medicine · doi:10.1080/07853890310001609 · Cited by 92 · see citing works
Some aspects of the SOS response system--a critical survey.
Janion, C. (2001) · Acta Biochimica Polonica · doi:10.18388/abp.2001_3894 · Cited by 91 · see citing works
Novel agents for the treatment of resistant Gram-positive infections
Woodford, N. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.2.117 · Cited by 91 · see citing works
Self-citationGestal, M. C., Tomás, M., Molina, F., Moure, R., Villanueva, R., & Bou, G. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2308-2313.2004 · Cited by 91 · see citing works
Epidemiology of the Genetic Elements Responsible for Acquired Glycopeptide Resistance in Enterococci
Woodford, N. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152652774 · Cited by 90 · see citing works
Self-citationBarnaud, G., Labia, R., Raskine, L., et al. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10519.x · Cited by 89 · see citing works
Boyle‐Vavra, S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.5.617 · Cited by 88 · see citing works
Genetic control of intrachromosomal recombination
Klein, H. L. (1995) · BioEssays · doi:10.1002/bies.950170210 · Cited by 86 · see citing works
Hashimoto, Y., Tanimoto, K., Ozawa, Y., Murata, T., & Ike, Y. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09070.x · Cited by 86 · see citing works
An Elevated Mutation Frequency Favors Development of Vancomycin Resistance in Staphylococcus aureus
Schaaff, F., Reipert, A., & Bierbaum, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3540-3548.2002 · Cited by 83 · see citing works
The frequency of mutators in populations of Escherichia coli
Boe, L., Danielsen, M., Knudsen, S., Petersen, J. B., Maymann, J., & Jensen, P. R. (2000) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(99)00239-0 · Cited by 82 · see citing works
İnce, D., Zhang, X., Silver, L. C., & Hooper, D. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.11.3370-3380.2002 · Cited by 80 · see citing works
Lobritz, M. A., Hutton‐Thomas, R., Marshall, S. H., & Rice, L. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3318-3320.2003 · Cited by 78 · see citing works
Novel Method for Rapid Determination of Clarithromycin Sensitivity in Helicobacter pylori
Gibson, J. R., Saunders, N. A., Burke, B., et al. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3746-3748.1999 · Cited by 77 · see citing works
Arthur, M., Depardieu, F., Reynolds, P. E., & Courvalin, P. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1875 · Cited by 77 · see citing works
Oxazolidinones: New antibacterial agents
Ford, C. W., Hamel, J. C., Stapert, D., et al. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01032-9 · Cited by 74 · see citing works
Gustafsson, I. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg427 · Cited by 71 · see citing works
Mammeri, H., Poirel, L., Bemer, P., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.716-720.2004 · Cited by 70 · see citing works
Lauderdale, T.-L. Y., McDonald, L. C., Shiau, Y., Chen, P., Wang, H.-Y., Lai, J., & Ho, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.525-527.2002 · Cited by 68 · see citing works
Pan, X.-S., Yagüe, G., & Fisher, L. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.11.3140-3147.2001 · Cited by 68 · see citing works
Macia, M. D., Borrell, N., Pérez, J. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2665-2672.2004 · Cited by 68 · see citing works
Fiett, J., Pałucha, A., ̨czyńska, B. M., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1499-1505.2000 · Cited by 67 · see citing works
Escherichia coli Cells Exposed to Streptomycin Display a Mutator Phenotype
Ren, L., Rahman, M. S., & Humayun, M. Z. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.3.1043-1044.1999 · Cited by 64 · see citing works
Ruggero, K. A., Schroeder, L. K., Schreckenberger, P. C., et al. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(03)00153-6 · Cited by 63 · see citing works
O’Neill, A. J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf118 · Cited by 62 · see citing works
Ribeiro, M. L., Gerrits, M. M., Benvengo, Y. H. B., Berning, M., Godoy, A. P. O., Kuipers, E. J., Mendonça, S., van Vliet, A. H. M., Pedrazzoli, J., & Kusters, J. G. (2003) · FEMS Immunology & Medical Microbiology · doi:10.1016/s0928-8244(03)00277-3 · Cited by 59 · see citing works
Kleibl, K. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00025-x · Cited by 58 · see citing works
Barnaud, G., Benzerara, Y., Gravisse, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.1040-1042.2004 · Cited by 56 · see citing works
Wachino, J., Kurokawa, H., Suzuki, S., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.534-541.2006 · Cited by 55 · see citing works
Direct Selection for Mutators in Escherichia coli
Miller, J. H., Suthar, A., Tai, J., Yeung, A., Truong, C., & Stewart, J. L. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.5.1576-1584.1999 · Cited by 54 · see citing works
Dina, J., Malbruny, B., & Leclercq, R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2307-2309.2003 · Cited by 53 · see citing works
Avison, M. B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.2.255 · Cited by 52 · see citing works
Depardieu, F., Courvalin, P. M., & Msadek, T. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03771.x · Cited by 49 · see citing works
Functions of the Mismatch Repair Gene mutS from Acinetobacter sp. Strain ADP1
Young, D. M., & Ornston, L. N. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.23.6822-6831.2001 · Cited by 47 · see citing works
Characterization of MarR Superrepressor Mutants
Alekshun, M. N., & Levy, S. B. (1999) · Journal of Bacteriology · doi:10.1128/jb.181.10.3303-3306.1999 · Cited by 43 · see citing works
Escherichia coli susceptible to glycopeptide antibiotics
Shlaes, D. M., Shlaes, J. H., DAVIES, J. E., & Williamson, R. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.2.192 · Cited by 42 · see citing works
Vakulenko, S. B., Golemi, D., Geryk, B., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1966-1970.2002 · Cited by 42 · see citing works
Role of a Mutation at Position 167 of CTX-M-19 in Ceftazidime Hydrolysis
Kimura, S., Ishiguro, M., Ishii, Y., Alba, J., & Yamaguchi, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1454-1460.2004 · Cited by 41 · see citing works
Very Low Cefotaxime Concentrations Select for Hypermutable Streptococcus pneumoniae Populations
Negri, M.-C., Morosini, M.-I., Baquero, M.-R., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.528-530.2002 · Cited by 40 · see citing works
Morosini, M.-I., Baquero, M.-R., Sánchez-Romero, J. M., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1464-1467.2003 · Cited by 39 · see citing works
Willems, R. J. L., Top, J., Smith, D. J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3061-3066.2003 · Cited by 35 · see citing works
Livermore, D. M. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.3.452 · Cited by 35 · see citing works
An extended-spectrum AmpC-type β-lactamase obtained by in vitro antibiotic selection
Morosini, M. I., Negri, M.-C., Shoichet, B. K., et al. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13131.x · Cited by 33 · see citing works
Halle, E., Padberg, J., Rosseau, S., et al. (2004) · Infection · doi:10.1007/s15010-004-3009-0 · Cited by 30 · see citing works
Neuwirth, C., Madec, S., Siébor, E., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3591-3594.2001 · Cited by 27 · see citing works
Ryan, K. A., van Doorn, L., Moran, A. P., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.5.1978-1980.2001 · Cited by 25 · see citing works
Spontaneous mutations in the Helicobacter pylori rpsL gene
Torii, N., Nozaki, T., Masutani, M., et al. (2003) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(02)00292-9 · Cited by 24 · see citing works
Effects of Ser130Gly and Asp240Lys Substitutions in Extended-Spectrum β-Lactamase CTX-M-9
Auméran, C., Chanal, C., Labia, R., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.2958-2961.2003 · Cited by 16 · see citing works
O’Neill, A. J., & Chopra, I. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1484-1485.2003 · Cited by 13 · see citing works
Koelbl, J. A., & Catlin, B. W. (1986) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.29.4.687 · Cited by 12 · see citing works
Muthaiyan, A., Jayaswal, R. K., & Wilkinson, B. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.623-625.2004 · Cited by 12 · see citing works
Castanheira, M., Mendes, R., Toleman, M., et al. (2003) · Cited by 6 · see citing works
Stockdale, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.06.004 · Cited by 5 · see citing works
Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes
Zimmermann, W. H., Fink, C., Kralisch, D., Remmers, U., Weil, J., & Eschenhagen, T. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000405)68:1
Flagged first, then by citations
Cited by
Sorted by citations
Bacterial charity work leads to population-wide resistance
Lee, H. H., Molla, M. N., Cantor, C. R., & Collins, J. J. (2010) · Nature · doi:10.1038/nature09354 · Cited by 638 · see citing works
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311 · see citing works
Evolutionary Emergence of Drug Resistance in Candida Opportunistic Pathogens
Ksiezopolska, E., & Gabaldón, T. (2018) · Genes · doi:10.3390/genes9090461 · Cited by 230 · see citing works
Ryall, B., Eydallin, G., & Ferenci, T. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05028-11 · Cited by 160 · see citing works
Use of Haploid Model of Candida albicans to Uncover Mechanism of Action of a Novel Antifungal Agent
Truong, T., Suriyanarayanan, T., Zeng, G., Le, T. D., Liu, L., Li, J., Tong, C., Wang, Y., & Seneviratne, C. J. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00164 · Cited by 16 · see citing works
Review and Comparison of Antimicrobial Resistance Gene Databases
Papp, M., & Solymosi, N. (2022) · doi:10.20944/preprints202202.0200.v1 · Cited by 97 · see citing works
- Authors
- Woodford, N., & Ellington, M. J.
- Affiliations
- Health Protection Agency (GB)
- Corresponding author
- Woodford, N.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2007-01
- Volume
- 13
- Issue
- 1
- Pages
- 5-18
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W1608826984
- Cited by
- 417
- References
- 174
- Citations by year
- 2026: 26 · 2025: 26 · 2024: 45 · 2023: 37 · 2022: 36 · 2021: 42 · 2020: 31 · 2019: 26 · 2018: 24 · 2017: 23 · 2016: 7 · 2015: 12 · 2014: 13 · 2013: 6 · 2012: 8
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Clinical Microbiology and Infection (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Antibiotic Resistance in Bacteria
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- antibiotic resistance, bacterial mutation, DNA repair, replication fidelity, TEM beta-lactamase, fluoroquinolone resistance, oxazolidinone resistance, horizontal gene transfer, Mycobacterium tuberculosis, Helicobacter pylori, Pseudomonas aeruginosa, cystic fibrosis, bacterial evolution
- MeSH terms
- Anti-Bacterial Agents, Bacteria, Drug Resistance, Biological Evolution, Genes, Bacterial, Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review